Episode 144 - Rituximab for EGPA
Update: 2025-11-27
Description
Welcome back Rounds Table Listeners! We are back today with a solo episode with Dr. John Fralick. This week, he discusses a recently published trial comparing rituximab with conventional strategy for the induction of remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Here we go!
- Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis: A Randomized Controlled Trial (0:00 – 5:40 ).
The Good Stuff (5:41 – 6:31 ):
- The I'm Pharmacy podcast, now featured on Medicine Pods: https://medicinepods.com/im-pharmacy/.
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
